Global Cancer Diagnostics Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>Market</strong> is expected to grow at a CAGR of 11.7% in<br />
the Forecast Period 2018-2025<br />
<strong>Cancer</strong> diagnostics industry accounted to USD XX.XX million in 2017 growing at a CAGR of<br />
XX.XX% during the forecast period of 2018 to 2025, <strong>Global</strong>ly. <strong>Cancer</strong> diagnostics market report<br />
contains data for historic years 2016, the base year of calculation is 2017 and the forecast<br />
period is 2018 to 2025.<br />
Get Sample Research Report: http://databridgemarketresearch.com/request-asample/?dbmr=global-cancer-diagnostics-market<br />
The major factors driving the growth of <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>Market</strong> are the growing with aging<br />
population worldwide, government initiatives for funding, and awareness about cancer. These<br />
factors increase the demand for cancer diagnostic products. On the other hand, stringent<br />
regulations imposed by international and local authorities and shortage of skilled and trained<br />
professionals may hinder the growth of the market. GE Healthcare is going to dominate the<br />
cancer diagnostics market, by imaging following with<br />
<br />
<br />
<br />
Siemens Healthcare GmbH<br />
Hologic, Inc,<br />
Becton, Dickinson & Company.<br />
Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform<br />
based following with Illumina, Inc. along with others such as Roche <strong>Diagnostics</strong>, Abbott<br />
Laboratories, Inc. Qiagen.<br />
Next Generation Sequencing (NGS) market is growing with the highest CAGR.<br />
<strong>Global</strong>ly biopsy is driving the market with highest market share.<br />
Magnetic Resonance Imaging (MRI) is dominating the cancer diagnostics imaging<br />
market.<br />
For TOC or Buy Full Report, Visit: https://databridgemarketresearch.com/toc/?dbmr=globalcancer-diagnostics-market<br />
Key Drivers:<br />
Some of the major factors driving the market for cancer diagnostics market are growing ageing<br />
population worldwide, government initiatives for funding and awareness about cancer. These<br />
factors increase the demand for cancer diagnostics products. Increasing prevalence of cancer,
key players focusing are on strategic decisions and technological advancements are the major<br />
factors driving the growth of the cancer diagnostics market.<br />
Stringent regulations imposed by the international and local authorities and shortage of<br />
the skilled and trained professionals are the factors which may hinder the growth of this<br />
market.<br />
Many companies are increasingly focusing on Next Generation Sequencing (NGS) and<br />
biopsy products in order to strengthen their product portfolios in the cancer diagnostics<br />
market.<br />
Increasing demand for Magnetic Resonance Imaging (MRI) and Next Generation<br />
Sequencing (NGS) will drive the market in future.<br />
<strong>Market</strong> Segmentation: <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
<br />
<br />
The global cancer diagnostics market is segmented on the basis of technology, application, and<br />
geography.<br />
The global cancer diagnostics market is segmented into two types,<br />
<br />
<br />
Platform based<br />
Instrument based<br />
<br />
<br />
In 2017, the cancer diagnostics instrument based segment is expected to dominate the market<br />
with a share of 68.8% and is expected to continue this trend till 2024.<br />
<strong>Cancer</strong> diagnostics platform based market is segmented into<br />
<br />
<br />
<br />
<br />
<br />
<br />
Polymerase chain reaction (PCR)<br />
In situ hybridization (ISH)<br />
Immunohisto chemistry (IHC)<br />
Next generation sequencing (NGS)<br />
DNA microarrays<br />
Flow cytometry and others<br />
<br />
<strong>Cancer</strong> <strong>Diagnostics</strong> instrument based market is segmented into<br />
<br />
<br />
Imaging<br />
Biopsy
Imaging is further segmented into<br />
<br />
<br />
<br />
<br />
<br />
Magnetic resonance imaging (MRI)<br />
Computed tomography (CT)<br />
Positron emission tomography- computed tomography (PET-CT)<br />
Mammography<br />
Ultrasound<br />
On the basis of application, the market is segmented into<br />
<br />
<br />
<br />
<br />
Lung <strong>Cancer</strong><br />
Breast <strong>Cancer</strong><br />
Colorectal <strong>Cancer</strong><br />
Melanoma And Others<br />
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-beforebuying/?dbmr=global-cancer-diagnostics-market<br />
About Us<br />
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our<br />
hard work with certitude. For Customization and Getting Discount on Report by emailing<br />
sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client<br />
satisfying rate.<br />
Contact Us<br />
Data Bridge <strong>Market</strong> Research<br />
Toll Free: +1-888-387-2818<br />
Mail: sopan.gedam@databridgemarketresearch.com<br />
http://databridgemarketresearch.com
Change language